Tag Archives: stomach cancer

December, 2017

• 4 December

  FDA Approves Ogivri, the First Biosimilar for Treatment of Certain Breast and Stomach Cancers

  

  HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, Dec. 1, 2017 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food and Drug Administration (FDA) has approved Mylan’s Ogivri™ (trastuzumab-dkst), a biosimilar to Herceptin® (trastuzumab), co-developed with Biocon. Ogivri has been approved for all indications included in the label of …

  Share

  • Facebook
  • Twitter
  • LinkedIn

April, 2015

• 14 April

  Study Finds Simple Breath Test Could Predict Stomach Cancer Risk

  

  Scientists have discovered a new simple breath test that can detect and predict whether an individual is at risk for stomach cancer. A new technology that analyzes and interprets patients’ “breath prints” – unique patterns of molecules people breathe in and out and reflect conditions in the body – is …

  Share

  • Facebook
  • Twitter
  • LinkedIn